Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism

Lehtovirta, M.; Kuikka, J.; Helisalmi, S.; Hartikainen, P.; Mannermaa, A.; Ryynänen, M.; Riekkinen, P. Sr.; Soininen, H.; Ryynänen, M; Riekkinen PSr
June 1998
Journal of Neurology, Neurosurgery & Psychiatry;Jun1998, Vol. 64 Issue 6, p742
Academic Journal
journal article
No abstract available.


Related Articles

  • Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. Kuusisto, Johanna; Koivisto, Keijo; Kervinen, Kari; Mykkanen, Leena; Helkala, Eeva-Liisa; Vanhanen, Matti; Hanninen, Tuomo; Pyorala, Kalevi; Kesaniemi, Y. antero; Riekkinen, Paavo; Laakso, Markku // BMJ: British Medical Journal (International Edition);9/10/94, Vol. 309 Issue 6955, p636 

    Examines the relationship between apolipoprotein E phenotypes and Alzheimer's disease in elderly. Frequency of apolipoprotein E e4 allele in Alzheimer patients; Prevalence of the disease in patients with no e4 allele; Objective of the study; Conclusion of the result.

  • Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Kamboh, M. Ilyas // Human Biology;Apr95, Vol. 67 Issue 2, p195 

    Studies the association of apolipoprotein E (ApoE) polymorphism with Alzheimer's disease (AD). ApoE's role in lipoprotein metabolism; Location of the ApoE gene; Biochemical and physiological characterization of ApoE; Mechanism of association of ApoE with AD.

  • Protein Gene Modulates: ALZHEIMER'S DISEASE.  // Research at Penn;2011, Vol. 9, p7 

    The article discusses a study that reveals the association between the apolipoprotein E ε4 gene (APOE ε4) and Alzheimer's disease.

  • APOE genotype predicts when ? not whether ? one is predisposed to develop Alzheimer disease. Meyer, Marion R; Tschanz, JoAnn T; Norton, Maria C; Welsh-Bohmer, Kathleen A; Steffens, David C; Wyse, Bonita W; Breitner, John C S // Nature Genetics;Aug98, Vol. 19 Issue 4, p321 

    Studies the occurrence of Alzheimer's disease (AD) in relation to apolipoprotein E (APOE) genotype. Identification of APOE alleles; Clinical assessment for cognitive dysfunction in AD patients; Disease-free survival by age for APOE genotypes.

  • α-2 macroglobulin gene and Alzheimer disease. Rudrasingham, Varuni; Wavrant-De Vrièze, Fabienne; Lambert, Jean-Charles; Chakraverty, Sumi; Kehoe, Patrick; Crook, Richard; Amouyel, Philippe; Wu, William; Rice, Frances; Pérez-Tur, Jordi; Frigard, Bernard; Morris, John C.; Carty, Stephanie; Petersen, Ronald; Cottel, Dominique; Tunstall, Nigel; Holmans, Peter; Lovestone, Simon; Chartier-Harlin, Marie-Christine // Nature Genetics;May99, Vol. 22 Issue 1, p17 

    Comments on D. Blacker and colleague's article about the association between Alzheimer's disease (AD) and an alpha-2-macroglobulin (A2M) insertion-deletion polymorphism. Detection of exon 18 mutation; Genotype distributions of A2M in relation to apolipoprotein E status.

  • A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's Disease. Lambert, Jean‐Charles; Pasquier, Florence; Cottel, Dominique; Frigard, Bernard; Amouyel, Philippe; Chartier‐Harlin, Marie‐Christine // Human Molecular Genetics;Mar1998, Vol. 7 Issue 3, p533 

    Studies the association between apolipoprotein E (APOE) gene polymorphism and Alzheimer's disease. Factors that facilitate amyloid substance deposition; Function of multiple class B proteins in the maintenance of the mammalian nervous system; Existence of genetic susceptibility factors within...

  • Dementia: Predicting its risk, APOE effects and disclosure of APOE genotype. Strupp, Michael // Journal of Neurology;Oct2009, Vol. 256 Issue 10, p1784 

    The article focuses on the studies done on the possible risk factors for the development of dementia. It offers information on a study performed to develop a late-life dementia risk index. It discusses a longitudinal growth modelling performed of the age-related memory decline and the...

  • APOE-ε4 and APOE -491A polymorphisms in individuals with subjective memory loss. Gandy, S.E.; Forstl, H.; Martins, R.N. // Molecular Psychiatry;2002, Vol. 7 Issue 7, p768 

    The accurate clinical diagnosis of Alzheimer's disease can only be made with a high degree of certainty in specialized centres. The identification of predictive or diagnostic genetic factors may improve accuracy of disease prediction or diagnosis. One major genetic risk factor, the ε4 allele...

  • Age, hypertension, and genetic polymorphisms and their relative associations with white matter hyperintensities in Korean patients with Alzheimer's disease. Heejeong Jeong; Seungnam Son; Soo-Kyoung Kim; Ki-Jong Park; Nack-Cheon Choi; Oh-Young Kwon; Byeonghoon Lim; Heeyoung Kang // Neurology Asia;Mar2015, Vol. 20 Issue 1, p35 

    Objectives: White matter hyperintensities are known to influence dementia in Alzheimer's disease. Genetic components are suggested as putative risk factors for vascular pathology and cognitive decline. This study aimed to determine whether there is an association between candidate genetic...

  • Discovery may help identify your risk of Alzheimer's disease.  // Mayo Clinic Health Letter;Jul1995, Vol. 13 Issue 7, p3 

    Reports on Alzheimer disease. Symptoms; Study by Mayo Clinic researchers; Carrier of the disease is a cholesterol carrying protein called apolipoprotein E 4 (APOE 4).


Read the Article


Sign out of this library

Other Topics